421 related articles for article (PubMed ID: 22925614)
41. Lipids, lipid-lowering therapy and diabetes complications.
Valensi P; Picard S
Diabetes Metab; 2011 Feb; 37(1):15-24. PubMed ID: 21126902
[TBL] [Abstract][Full Text] [Related]
42. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.
Amend KL; Landon J; Thyagarajan V; Niemcryk S; McAfee A
Ann Pharmacother; 2011 Oct; 45(10):1230-9. PubMed ID: 21917557
[TBL] [Abstract][Full Text] [Related]
43. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
44. Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus.
Reyes-Soffer G; Rondon-Clavo C; Ginsberg HN
Expert Opin Pharmacother; 2011 Jun; 12(9):1429-38. PubMed ID: 21426238
[TBL] [Abstract][Full Text] [Related]
45. Fibrates in combination with statins in the management of dyslipidemia.
Jacobson TA; Zimmerman FH
J Clin Hypertens (Greenwich); 2006 Jan; 8(1):35-41; quiz 42-3. PubMed ID: 16407687
[TBL] [Abstract][Full Text] [Related]
46. [Fibrates].
Hara F; Yamazaki J
Nihon Rinsho; 2013 Sep; 71(9):1643-8. PubMed ID: 24205728
[TBL] [Abstract][Full Text] [Related]
47. Myopathy with statin-fibrate combination therapy: clinical considerations.
Jacobson TA
Nat Rev Endocrinol; 2009 Sep; 5(9):507-18. PubMed ID: 19636324
[TBL] [Abstract][Full Text] [Related]
48. Optimal pharmacotherapy to combat the atherogenic lipid triad.
Chapman MJ; Redfern JS; McGovern ME; Giral P
Curr Opin Cardiol; 2011 Sep; 26(5):403-11. PubMed ID: 21730827
[TBL] [Abstract][Full Text] [Related]
49. Use of fibrates in the United States and Canada.
Jackevicius CA; Tu JV; Ross JS; Ko DT; Carreon D; Krumholz HM
JAMA; 2011 Mar; 305(12):1217-24. PubMed ID: 21427374
[TBL] [Abstract][Full Text] [Related]
50. Micronized fenofibrate: a new fibric acid hypolipidemic agent.
Guay DR
Ann Pharmacother; 1999 Oct; 33(10):1083-103. PubMed ID: 10534222
[TBL] [Abstract][Full Text] [Related]
51. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
52. Combination lipid-lowering therapy in diabetes.
Davidson MH
Curr Diab Rep; 2003 Jun; 3(3):263-8. PubMed ID: 12762976
[TBL] [Abstract][Full Text] [Related]
53. [Multimodal therapy of dyslipidemia].
Stahn A; Hanefeld M
Clin Res Cardiol Suppl; 2011 May; 6():10-6. PubMed ID: 22528173
[TBL] [Abstract][Full Text] [Related]
54. [Fibrates].
Yamada N
Nihon Rinsho; 2002 May; 60(5):962-7. PubMed ID: 12030000
[TBL] [Abstract][Full Text] [Related]
55. Effects of fibrates on serum metabolic parameters.
Elisaf M
Curr Med Res Opin; 2002; 18(5):269-76. PubMed ID: 12240789
[TBL] [Abstract][Full Text] [Related]
56. [Residual risk of cardiovascular complications and its reduction with a combination of lipid lowering agents].
Soska V
Vnitr Lek; 2011 Mar; 57(3):313-6. PubMed ID: 21495414
[TBL] [Abstract][Full Text] [Related]
57. Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
Wierzbicki AS
Curr Opin Lipidol; 2010 Aug; 21(4):352-8. PubMed ID: 20625256
[TBL] [Abstract][Full Text] [Related]
58. Fibrates and niacin: is there a place for them in clinical practice?
Wierzbicki AS; Viljoen A
Expert Opin Pharmacother; 2014 Dec; 15(18):2673-80. PubMed ID: 25318657
[TBL] [Abstract][Full Text] [Related]
59. Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia.
Filippatos TD; Elisaf MS
Expert Opin Pharmacother; 2011 Aug; 12(12):1945-58. PubMed ID: 21736529
[TBL] [Abstract][Full Text] [Related]
60. Choosing drug therapy for patients with hyperlipidemia.
Safeer RS; Lacivita CL
Am Fam Physician; 2000 Jun; 61(11):3371-82. PubMed ID: 10865931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
